Scientific expertise for research, industry and evidence-based decision-making.
Led by Professor Gavin Reid, KTI Research provides specialist expertise in research strategy, grant funding, infrastructure development, researcher capability-building, industry engagement, and collaborative bioanalytical mass spectrometry-based research, while also offering independent expert opinion services to translate complex chemical and biological data into clear, reliable evidence for scientific, legal and regulatory contexts.
Professional Services
KTI Research provides specialist consulting across three connected areas: collaborative research, strategic grant development and research infrastructure advisory services, and independent expert opinion work. Led by Professor Gavin Reid, the service is designed for organisations that need to address complex questions in the physical and life sciences with clarity, confidence and scientific rigour.
Clients can access deep expertise in grant development, major research infrastructure facility development and management, researcher capacity building, analytical and biological mass spectrometry, proteomics, lipidomics, and technical evidence interpretation. Where a project requires additional subject matter expertise, KTI Research can also draw on a trusted network of specialist collaborators.
Whether supporting a research partnership, advising on grant funding or infrastructure strategy, or translating complex data into clear evidence for legal, regulatory or organisational decision-making, KTI Research helps clients move from scientific complexity to practical, informed action.
-
KTI Research supports collaborative research in bioanalytical mass spectrometry-based proteomics and lipidomics. Drawing on Professor Gavin Reid’s internationally recognised expertise, this service is designed for academic, industry, government and multidisciplinary partners seeking specialist input into experimental design, method development, biomolecular analysis, data interpretation and the application of mass spectrometry to solve complex biological questions.
With more than four decades of experience across Australia and the United States, Gavin brings a highly collaborative approach to research partnerships. His work has contributed to major advances in mass spectrometry instrumentation, chemical strategies and biological applications, particularly in understanding the role of lipids and proteins in disease.
-
KTI Research translates complex chemical and biological information into clear, evidence-based insights. This includes the specialist interpretation of analytical data, scientific methods, technical findings and biomolecular evidence, particularly where advanced mass spectrometry expertise for chemical and biological analysis is required.
Through this pillar, Gavin supports legal, regulatory, industry and government decision-making by making complex science understandable, defensible and useful. His experience providing expert consulting, testimony and technical submissions enables him to bridge the gap between specialist scientific detail and the practical clarity required in formal, high-stakes or interdisciplinary contexts.
-
KTI Research helps researchers, institutions and organisations turn scientific expertise into meaningful, sustainable outcomes. Professor Gavin Reid brings extensive experience in research strategy, grant development, infrastructure planning, researcher capability building, and industry engagement to support stronger, more competitive research programs.
This service is especially suited to teams seeking to grow their research capacity, develop and strengthen funding applications, plan or optimise research infrastructure, mentor emerging researchers, or shape collaborative initiatives with long-term value. Drawing on leadership roles at the University of Melbourne and the Australian Research Council, Gavin helps partners build the strategic foundations, skills and systems needed to translate research effort into practical impact.
Professor Gavin Reid
Professor Gavin E. Reid, PhD, is the founder of KTI Research and an internationally recognised authority in bioanalytical mass spectrometry. With a career spanning four decades across Australia and the United States, Gavin has built a reputation for research excellence, strategic research leadership and the translation of complex analytical data into meaningful insights.
Driven by the belief that innovations in technology enable biomedical discovery and translation, Gavin’s research expertise sits at the intersection of the analytical and biological sciences, with a particular focus on the development of mass spectrometry instrumentation and associated chemical strategies for biomolecular analysis in the fields of proteomics and lipidomics, and their applications to identify the functional role of proteins and lipids in the onset and progression of disease. To date, this highly collaborative research has produced more than 200 peer-reviewed publications in leading journals including Nature, Cell, PNAS, Journal of the American Chemical Society, Analytical Chemistry and Mass Spectrometry Reviews, alongside four patents and more than 160 plenary, keynote, invited and conference presentations.
Since starting his independent career in 2002, Gavin has attracted >AUD$50M in competitive research and infrastructure grant funding, of which >AUD$20M he has led and managed as first named Chief Investigator. This includes major support from the ARC (multiple Discovery Project grants and LIEF grants, an ARC Training Center, and a Centre of Excellence), the National Health and Medical Research Council (multiple Project and Ideas grants), the USA National Institutes of Health (NIH) (multiple R01, R21 and R56 grants), and the USA National Science Foundation (NSF) (CAREER and project grants). He has been a regular reviewer and/or grant review panel member for each of these funding agencies, as well as others including the Medical Research Future Fund (MRFF).
Gavin’s contributions to the field have been recognised through multiple awards and honours, including election as a Fellow of the Australian and New Zealand Society for Mass Spectrometry (ANZSMS), the ANZSMS Morrison and Bowie Medals, an American Society for Mass Spectrometry (ASMS) Research Award, an NSF CAREER Award and a Victorian Young Tall Poppy Award. He has also held major service roles across the mass spectrometry, proteomics and lipidomics research communities, including as President of ANZSMS, as Treasurer of the Australasian Proteomics Society (APS), as the Member at Large for Education on the Board of Directors of ASMS, as Associate Editor of the Journal of the American Society for Mass Spectrometry, as a member of the Editorial Advisory Boards for the Journal of Proteome Research and the Journal of Lipid Research, and finally as Convener and Chair of the 25th International Mass Spectrometry Conference in Melbourne.
Alongside his research achievements, Gavin has held significant academic institutional and national leadership roles, including at the University of Melbourne where he was appointed from 2014-2026 as The Professor of Bioanalytical Chemistry in the School of Chemistry, and a Professor in the Department of Biochemistry and Pharmacology. From 2017-2019, he was the Assistant Dean (Industry) and Acting Associate Dean (Research and Industry) and in 2023 served as Associate Dean (Infrastructure) in the Faculty of Science at the University of Melbourne. From 2023 to 2025, Gavin was seconded to the Australian Research Council (ARC) as the Executive Director for Mathematics, Physics, Chemistry and Earth Sciences, where he played a key role in supporting the development of grant guidelines, eligibility, peer review, assessment and selection processes for applications to the National Competitive Grants Program (NCGP), with lead responsibility for the Linkage Project Grant scheme, and the Linkage Early-, Mid- and Laureate Industry Fellowship schemes, while also contributing to policy and legislation development including for the 2024-2025 Policy Review of the National Competitive Grants Program (NCGP), the 2024 ARC Policy Statement on Experimental Development, and with lead responsibility for reform of the ARC Medical Research Policy (2025 version). While at the ARC, he also developed and delivered workshops on grant application development and researcher capacity building to University academics and research office staff, and liaised with academic partners and other stakeholders across industry, government and the broader research and innovation sector to identify emerging disciplinary and cross-disciplinary developments and innovative approaches to research and innovation.
Through KTI Research, Gavin brings his depth of experience to collaborative research, grant funding and infrastructure advisory services, research capability building, and independent expert opinion work. His extensive consulting experience includes engagement with national and international industry groups, government agencies, research organisations and legal or regulatory contexts, where he helps interpret and translate complex chemical and biological data into clear, evidence-based guidance for decision-making.